Monitoring neuromuscular function during gastric bypass surgery
A Before/After Study of the Impact of Quantitative Neuromuscular Monitoring and Sugammadex Reversal Following Gastric Bypass Surgery
This study looks at how keeping track of muscle function during gastric bypass surgery can help patients recover better and feel safer after the operation.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 215 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of California, Davis Academic / other |
| Locations | 1 site (Sacramento, California) |
| Trial ID | NCT05886218 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate how monitoring and reversal guidelines for neuromuscular blocking drugs affect post-operative outcomes in patients undergoing laparoscopic gastric bypass surgery. It is a single-site, prospective, non-blinded, and non-randomized before/after study. The focus is on the use of quantitative neuromuscular function monitoring to improve patient recovery and safety during and after the surgical procedure.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years scheduled for elective laparoscopic gastric bypass surgery.
Not a fit: Patients under 18, pregnant individuals, those with significant lung diseases, or requiring supplemental oxygen pre-operatively may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved recovery times and reduced complications for patients undergoing gastric bypass surgery.
How similar studies have performed: While this specific approach is not widely tested, similar studies on neuromuscular monitoring have shown promising results in improving surgical outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age greater than 18 years * scheduled for an elective laparoscopic gastric bypass procedure Exclusion Criteria: * age less than 18 years * pregnancy * prisoners * significant co-existing lung disease including asthma or chronic obstructive pulmonary disease (COPD) requiring regular medication * patients who require supplemental oxygen pre-operatively to maintain a hemoglobin saturation (SpO2\>98%)
Where this trial is running
Sacramento, California
- UC Davis Medical Center — Sacramento, California, United States (Recruiting)
Study contacts
- Study coordinator: Ana P Arias, BS
- Email: apaarias@ucdavis.edu
- Phone: 916-703-5456
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.